Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ophthalmic Equipment Companies

Ophthalmic equipment companies specialize in the development, manufacturing, and distribution of medical devices and equipment used in the diagnosis, treatment, and management of various eye conditions and disorders. These companies play a crucial role in supporting ophthalmologists, optometrists, and eye care professionals in delivering high-quality eye care services.

Ophthalmic Equipment Key Companies

 

Latest Ophthalmic Equipment Companies Update


Johnson & Johnson (US) Received FDA approval for their Tecnis Symfony® Extended IOL, offering wider range of vision and potentially reducing dependence on reading glasses for cataract patients with presbyopia.Continued advancements in their iTEAR® technology for developing next-generation artificial tears with improved efficacy and patient preference.


Alcon (Switzerland) Announced positive topline results from Phase 3 trials for AR-15512, a novel investigational therapy for Dry Eye Syndrome (DES) with potential to alleviate inflammation and stabilize the tear film.Launched their innovative VerifEye™ Anterior Segment OCT system, enabling real-time visualization of corneal and meibomian gland structures for improved DES diagnosis and treatment planning.


Zeiss (Germany) Launched ZEISS trifocal technology on a glistening-free hydrophobic c-loop platform and a fully preloaded injector for safe and reliable implantation in cataract surgery.Collaborated with Boehringer Ingelheim to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.


Santen Pharmaceutical Co. Announced successful Phase 2 results for MK-5351, a first-in-class topical therapy for DES targeting neurogenic inflammation, potentially offering a novel treatment approach.Introduced their innovative TearCare® LifeStyle Mask, combining gentle heat and pulsation to improve meibomian gland function and alleviate DES symptoms.


Paragon Medical (US) Launched their novel HydraLens® contact lens for DES patients, featuring advanced moisture retaining technology for lasting comfort and improved tear film stability.Partnered with leading ophthalmologists to develop specialized contact lens fitting protocols for individuals with DES.


List of Ophthalmic Equipment Key Companies in the Market



  • Alcon

  • Bausch & Lomb

  • Carl Zeiss Meditec

  • Johnson & Johnson

  • Essilor International S.A.

  • Haag-Streit

  • Nidek

  • Staar Surgical

  • Topcon Corporation

  • Ziemer Ophthalmic Systems

  • Hoya Corporation

  • Ridex Corporation


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.